ONCOGENEX PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ONCOGENEX PHARMACEUTICALS IN PUT, CUSIP 68230A956.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ONCOGENEX PHARMACEUTICALS IN PUT, CUSIP 68230A956.